Literature DB >> 10585758

Heterogeneity of anti-dsDNA antibodies in their cross-reaction with ribosomal P protein.

I Takeda1, K Rayno, M Wolfson-Reichlin, M Reichlin.   

Abstract

We have investigated the possible cross-reaction of anti-dsDNA antibodies with ribosomal P peptide for several reasons. First, the antibodies frequently occur together, and secondly, they vary similarly with disease activity. Human polyclonal anti-dsDNA antibodies were affinity purified from eight patients and anti-ribosomal P antibodies from two patients with systemic Lupus erythematosus (SLE) who had high titers of anti-dsDNA as well as anti-ribosomal P antibodies. Nine of the 10 sera were totally specific in their reactivity with their cognate antigens. In only one patient did we find a subpopulation of antibodies which cross-reacted with both dsDNA and the carboxyl terminal 22 amino acid peptide. Our results indicate that anti-dsDNA antibodies are heterogeneous and usually do not cross-react with the carboxyl terminal P peptide, but on occasion (1/10) a patient will produce anti-dsDNA antibodies cross-reactive with the carboxyl terminal P peptide. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585758     DOI: 10.1006/jaut.1999.0330

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.

Authors:  M Mahler; K Kessenbrock; J Raats; R Williams; M J Fritzler; M Blüthner
Journal:  J Mol Med (Berl)       Date:  2003-03-14       Impact factor: 4.599

2.  International multicenter evaluation of autoantibodies to ribosomal P proteins.

Authors:  Michael Mahler; Kai Kessenbrock; Magdalena Szmyrka; Yoshinari Takasaki; Ignacio Garcia-De La Torre; Yehuda Shoenfeld; Falk Hiepe; Chen Shun-le; Carlos A von Mühlen; Henning Locht; Peter Höpfl; Allan Wiik; Westley Reeves; Marvin J Fritzler
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Anti-ribosomal antibodies from lupus patients bind DNA.

Authors:  L Caponi; D Chimenti; F Pratesi; P Migliorini
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Antibodies elicited in response to EBNA-1 may cross-react with dsDNA.

Authors:  Pragya Yadav; Hoa Tran; Roland Ebegbe; Paul Gottlieb; Hui Wei; Rita H Lewis; Alice Mumbey-Wafula; Atira Kaplan; Elina Kholdarova; Linda Spatz
Journal:  PLoS One       Date:  2011-01-04       Impact factor: 3.240

5.  Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.

Authors:  Benjamin F Bruner; Joel M Guthridge; Rufei Lu; Gabriel Vidal; Jennifer A Kelly; Julie M Robertson; Diane L Kamen; Gary S Gilkeson; Barbara R Neas; Morris Reichlin; R Hal Scofield; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2012-11

Review 6.  The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

Review 7.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

8.  Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.